Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
GRAND CAYMAN, Cayman Islands, May 21, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech company developing RNA interference...
-
Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "miRNA Sequencing and Assays - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for miRNA...
-
Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "RNAi Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's...
-
Houston, May 20, 2025 (GLOBE NEWSWIRE) -- Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by...
-
Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Europe Contract Research Organization Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type,...
-
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- Pathos AI, a leading AI-driven biotech company applying cutting-edge artificial intelligence to drug development, today announced its $365 million Series D...
-
GRAND CAYMAN, Cayman Islands, May 13, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech company developing RNA interference...
-
Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Precision Medicine Market: Focus on Ecosystem and Country - Analysis and Forecast, 2024-2034" report has been added to ...
-
Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Precision Medicine Market - A Global and Regional Analysis: Focus on Ecosystem, Application, and Region - Analysis and Forecast, 2024-2034" report has...
-
SAN DIEGO, May 09, 2025 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biotechnology company focused on the design and development of small molecule medicines...